Business Description
Vaxcyte is a clinical-stage biotechnology company focused on developing next-generation vaccines to protect against serious bacterial infections. Its pipeline includes several investigational vaccines targeting pneumococcal disease in both children and adults, as well as candidates aimed at Group A Streptococcus, the bacteria behind gum disease, and dysentery-causing Shigella. Founded in 2013 and based in San Carlos, California, the company was previously known as SutroVax before rebranding in 2020.
